Celcuity, Inc. (CELC)
106.75
+2.47
(+2.37%)
USD |
NASDAQ |
Feb 06, 16:00
106.70
-0.05
(-0.05%)
After-Hours: 20:00
Celcuity EPS Diluted (Quarterly) : -0.9204 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 0.219 |
| Cidara Therapeutics, Inc. | -3.096 |
| Cogent Biosciences, Inc. | -0.5884 |
| Relay Therapeutics, Inc. | -0.4301 |
| Olema Pharmaceuticals, Inc. | -0.4924 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -43.80M |
| Total Expenses (Quarterly) | 43.80M |
| Enterprise Value | 4.805B |
| Earnings Yield | -3.44% |
| Normalized Earnings Yield | -3.439 |